Industry Landscape

Extractables and Leachables (E&L) has become crucial aspect in the pharmaceutical industry due to stringent regulatory guidelines for increased patient safety. The pharma E&L testing market is expected to expand at a compound annual growth rate of 12.1% from 2015 to 2020. This growth is driven by the increasing adoption of single-use technologies and rigorous inspections by regulatory agencies. CRO'S are also evolving as development partners thereby further expanding the need for E&L studies. Emerging markets such as India and China are becoming hubs for contract manufacturing for such services, as these countries are building strong local expertise in analytical laboratory testing.

About Pharma Extractables & Leachables Forum

All Pharmaceutical products come in contact with external components right from the manufacturing process till the actual consumption. During this process small amounts of chemicals may be extracted/ leached upon contact with other material which poses a health risk to the patient. E&L studies therefore play an important role in verifying the safety of a drug product over its lifetime. Recently USFDA is increasingly taking interest in the interactions of pharma packaging material, containers and delivery devices with drug product or patient.

CPhI Conferences is organizing the Pharma Extractables and Leachables Forum taking place from 6 - 7 February 2020 in Hyderabad. This is a perfect platform for professional to build a strong foundation for successful E&L Studies. The E&L forum will bring together many different skill sets from a number of different disciplines.